Colorado Springs, Colo. (October 20, 2017) – USADA announced today that UFC® athlete Carlos Felipe Cabral de Almeida, known professionally as Carlos Felipe, of Feira de Santana, Brazil, has accepted a two-year sanction after testing positive for a prohibited substance.
Felipe, 22, tested positive for stanozolol metabolites, 16β‐hydroxy‐stanozolol and 3’‐hydroxy‐stanozolol, following an out-of-competition urine test conducted on July 29, 2017. Stanozolol is a non-Specified Substance in the category of Anabolic Agents and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List.
Felipe’s two-year period of ineligibility began on September 19, 2017, the date his provisional suspension was imposed. As a result of his positive test, Felipe was removed from the Card for the UFC Fight Night event in Sao Paulo, Brazil, scheduled for October 28, 2017.
Pursuant to the UFC Anti-Doping Policy, all UFC athletes serving a period of ineligibility for an anti-doping policy violation are required to remain in the USADA registered testing pool and make themselves available for testing in order to receive credit for time completed under his or her sanction.